1. Home
  2. HUSA vs CGTX Comparison

HUSA vs CGTX Comparison

Compare HUSA & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUSA
  • CGTX
  • Stock Information
  • Founded
  • HUSA N/A
  • CGTX 2007
  • Country
  • HUSA United States
  • CGTX United States
  • Employees
  • HUSA N/A
  • CGTX N/A
  • Industry
  • HUSA Oil & Gas Production
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUSA Energy
  • CGTX Health Care
  • Exchange
  • HUSA Nasdaq
  • CGTX Nasdaq
  • Market Cap
  • HUSA 16.9M
  • CGTX 30.0M
  • IPO Year
  • HUSA N/A
  • CGTX 2021
  • Fundamental
  • Price
  • HUSA $1.42
  • CGTX $0.63
  • Analyst Decision
  • HUSA
  • CGTX Strong Buy
  • Analyst Count
  • HUSA 0
  • CGTX 6
  • Target Price
  • HUSA N/A
  • CGTX $8.30
  • AVG Volume (30 Days)
  • HUSA 3.0M
  • CGTX 1.3M
  • Earning Date
  • HUSA 11-14-2024
  • CGTX 03-25-2025
  • Dividend Yield
  • HUSA N/A
  • CGTX N/A
  • EPS Growth
  • HUSA N/A
  • CGTX N/A
  • EPS
  • HUSA N/A
  • CGTX N/A
  • Revenue
  • HUSA $640,348.00
  • CGTX N/A
  • Revenue This Year
  • HUSA N/A
  • CGTX N/A
  • Revenue Next Year
  • HUSA N/A
  • CGTX N/A
  • P/E Ratio
  • HUSA N/A
  • CGTX N/A
  • Revenue Growth
  • HUSA N/A
  • CGTX N/A
  • 52 Week Low
  • HUSA $0.96
  • CGTX $0.34
  • 52 Week High
  • HUSA $3.20
  • CGTX $2.95
  • Technical
  • Relative Strength Index (RSI)
  • HUSA 45.28
  • CGTX 41.97
  • Support Level
  • HUSA $1.43
  • CGTX $0.70
  • Resistance Level
  • HUSA $1.75
  • CGTX $0.82
  • Average True Range (ATR)
  • HUSA 0.25
  • CGTX 0.06
  • MACD
  • HUSA -0.05
  • CGTX -0.02
  • Stochastic Oscillator
  • HUSA 4.55
  • CGTX 12.98

About HUSA Houston American Energy Corporation

Houston American Energy Corp is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its properties, and operations, are in the U.S. Permian Basin, the U.S. Gulf Coast region, particularly Texas and Louisiana, and the South American country of Colombia. The company's exploration and development projects are focused on existing property interests, and future acquisition of additional property interests, in the Texas Permian Basin, the onshore Texas and Louisiana Gulf Coast region, and the South American country of Colombia. The Company majorly has operations in two geographical areas, the United States and Colombia.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: